Csenge Advisory Group’s TC BioPharm (Holdings) plc Warrants TCBPW Stock Holding History

Csenge Advisory Group’s Portfolio TCBPW Stock Details TCBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23,862	Closed	-$236	–	758
2024 Q4	$236	Buy	23,862 +5,000	+27%	+$87	﹤0.01%	694
2024 Q3	$472	Buy	+18,862	New	+$287	﹤0.01%	706

Csenge Advisory Group's TCBPW Position: Q1 2025 in Review

Csenge Advisory Group sold out of TC BioPharm (Holdings) plc Warrants (TCBPW) in Q1 2025, closing a stake of 23,862 shares — an estimated $236 sold.

Csenge Advisory Group first reported a position in TCBPW in Q3 2024 and held it in 2 quarters. The position peaked at $472 in Q3 2024. 0 funds tracked by Wall St. Rank hold TCBPW as of Q1 2025.

Csenge Advisory Group reported no remaining TC BioPharm (Holdings) plc Warrants position as of Q1 2025 after selling out during the quarter.
Csenge Advisory Group sold 23,862 TC BioPharm (Holdings) plc Warrants shares in Q1 2025, an estimated $236.
Csenge Advisory Group first reported a position in TC BioPharm (Holdings) plc Warrants in Q3 2024 and held it in 2 quarters.
Csenge Advisory Group's TC BioPharm (Holdings) plc Warrants position peaked at $472 in Q3 2024.
0 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc Warrants as of Q1 2025.

Based on Csenge Advisory Group's 13F filing for Q1 2025, filed 5 May 2025.